GoHealthcare Practice Solutions

Thoracic Medial Branch Block

Medical Necessity, Prior Authorization, Documentation, Coding, Reimbursement, and Denial Prevention

The authorization is not for a generic mid-back injection. It is for a level-specific, side-specific diagnostic or prognostic block that must remain aligned with the intended thoracic radiofrequency ablation pathway and the member-specific payer policy.

Request Help View Case Studies

GoHealthcare Results

Company-reported operational performance across specialty prior authorization and healthcare practice support engagements.

25+ YearsHealthcare operations experience

500+ Physicians and GroupsServed across specialty practices

3.5M+ Prior AuthorizationsRequests processed

98% Approval RateCompany-reported authorization approval rate

Results vary by client, payer, specialty, case mix, and contracted scope.

Request Help Explore Case Studies

Case Study Library: https://www.gohealthcarellc.com/case-studies.html

How to Use This Resource

This publication is designed for physicians, APPs, practice administrators, prior authorization specialists, utilization management nurses, coders, revenue cycle professionals, ambulatory surgery centers, hospitals, and healthcare executives. It is an operational and reimbursement resource, not a substitute for the member benefit, live payer policy, Medicare contractor instruction, current CPT and ICD-10-CM code sets, or clinician judgment. Verify the controlling policy and code set before every submission, procedure, and claim.

Critical distinction A thoracic medial branch block is a diagnostic or prognostic test of the nerves supplying one or more thoracic facet joints. It is not the same as an intra-articular facet injection, thoracic epidural steroid injection, costovertebral or costotransverse joint injection, trigger point injection, or thoracic medial branch radiofrequency ablation. The order, authorization, procedure note, outcome record, and claim must use consistent terminology.

Procedure Navigation

Select a section to review clinical, policy, coding, documentation, reimbursement, or operational requirements.

Sections 1-9

1. Executive Overview
2. Evidence at a Glance
3. Procedure Definition and Relevant Thoracic Anatomy
4. Distinguishing Thoracic MBB from Related Procedures
5. Clinical Indications and Patient Selection
6. Contraindications and Safety Considerations
7. Medical Necessity Requirements
8. Conservative Treatment and Care-Pathway Sequencing
9. CMS National Guidance and NCD Review

Sections 10-18

1. Medicare LCD Requirements
2. Medicare Billing and Coding Articles and MAC Variation
3. Medicare Hospital Outpatient Prior Authorization
4. Commercial Payer Policies
5. BCBS Policy Variation
6. Carelon, eviCore, Cohere, and Evolent
7. Clinical Evidence and Specialty-Society Guidance
8. Policy and Guideline Comparison Matrix
9. Prior Authorization Workflow

Sections 19-27

1. Clinical Documentation Requirements
2. Documentation Pearls
3. CPT and HCPCS Coding
4. ICD-10-CM Crosswalk
5. Modifiers, Units, NCCI, MUE, and Place of Service
6. Reimbursement Considerations
7. Denial Prevention
8. Common Denial Reasons and Corrective Actions
9. Appeals and Peer-to-Peer Preparation

Sections 28-36

1. Workflow Optimization and Quality Controls
2. Operational KPIs
3. Payer Perspective
4. Clinical Pearls
5. GoHealthcare Perspective
6. GoHealthcare Insights
7. Frequently Asked Questions
8. Related Procedures
9. References and Related Readings

1

Procedure Library

Executive Overview

A thoracic medial branch block, commonly abbreviated MBB, is an image-guided injection of local anesthetic at one or more medial branch nerves that transmit sensory input from thoracic zygapophyseal joints. Its principal operational role is diagnostic or prognostic: the block helps determine whether a specific thoracic facet joint or joint set is a clinically meaningful pain generator and whether the patient may qualify for thoracic medial branch radiofrequency ablation under the controlling payer pathway. Thoracic requests require extra policy verification because some payers cover thoracic MBB, while others exclude the thoracic region except at junctional levels.

The procedure is common, but authorization is unforgiving. The diagnosis, pain pattern, conservative-care history, examination, level selection, laterality, imaging exclusions, prior block response, and intended downstream treatment must align. A technically successful block can still create a denial if the request is described as therapeutic when the payer covers only diagnostic MBB, if a steroid-containing injectate conflicts with the vendor rule, if the physician orders nerve levels while the authorization is issued by joint level, or if the post-block outcome is documented without the baseline scale, percent relief, duration, and activity context required for confirmatory testing or RFA.

Medicare LCDs generally require chronic predominantly axial pain, functional deficit, at least three months of symptoms, failure of noninvasive conservative care, absence of untreated radiculopathy or another better pain generator, fluoroscopy or CT, and a consistent positive response of at least 80% after the first diagnostic procedure before a second confirmatory procedure. Commercial payer thresholds, permitted levels, required number of blocks, intervals, injectate restrictions, and RFA prerequisites vary. The authorization team must use the live policy governing the member rather than treating any one guideline as universal.

Back to procedure navigation

2

Procedure Library

Evidence at a Glance

Domain	Operational conclusion
Primary purpose	Diagnostic or prognostic identification of thoracic facet-mediated pain, usually before radiofrequency ablation when thoracic RFA is covered.
Pain pattern	Predominantly axial thoracic or mid-back pain with functional impairment. Thoracic radiculopathy, myelopathy, rib or chest-wall pain, visceral disease, or another dominant generator moves the case out of the routine facet pathway.
Target logic	The block targets medial branch nerves supplying the suspected thoracic facet joint. Count the joint level evaluated, not the number of nerves, needles, or targets.
Response threshold	Medicare and many commercial or delegated UM pathways require at least 80% relief for the expected duration of the anesthetic. Some clinical consensus guidance discusses lower thresholds, but coverage rules control authorization.
Number of blocks	Dual diagnostic blocks are common before RFA. A single block may be accepted by some plans or clinical pathways, but it should never be assumed.
Image guidance	Fluoroscopy or CT is the standard coverage pathway. Ultrasound may be discussed in clinical literature but is noncovered or excluded under multiple payer policies.
Injectate	Diagnostic MBB is generally performed with local anesthetic. Steroid may convert or confuse the request as therapeutic. Carelon uses local-anesthetic-only criteria at the limited thoracic junctional levels it covers.
Levels	Medicare generally allows one or two levels, unilateral or bilateral, per session per spinal region. Commercial policies vary; some cover thoracic levels, while Carelon excludes routine thoracic intervention except C7-T1 and T12-L1.
Frequency	Medicare permits no more than four diagnostic facet sessions per covered spinal region in a rolling 12 months. Vendor limits vary.
Coding	CPT 64490 is the first cervical/thoracic facet level and 64491 is the second. CPT 64492 represents a third and additional level, but Medicare generally does not cover three- or four-level sessions.
Primary denial risk	The payer or delegated UM entity excludes the requested thoracic level, or the request lacks a precise diagnostic MBB-to-RFA pathway and complete prior-block response.

Back to procedure navigation

3

Procedure Library

Procedure Definition and Relevant Thoracic Anatomy

The thoracic facet joints are paired synovial joints from the upper through lower thoracic spine. They guide motion and interact mechanically with the rib cage, costovertebral joints, costotransverse joints, discs, paraspinal musculature, and adjacent neural structures. Mid-back pain can arise from several of these structures, so imaging findings alone do not prove facet-mediated pain. A diagnostic block is used because history, examination, and imaging are not sufficiently specific to confirm the painful joint in isolation.

Thoracic facet-joint innervation is segmental and can vary by level. Operationally, the procedure order and authorization must map the targeted medial branch nerves to the thoracic joint level or levels being evaluated. The number of nerves injected is not the number of facet levels billed. Coding and utilization controls count the joint level, not the number of needles or nerve targets.

Thoracic level and target terminology

• A facet level is the joint being tested. A bilateral block at the same joint level remains one level for coding and utilization purposes.
• The physician may target more than one medial branch nerve to evaluate one thoracic joint. That does not create multiple billable facet levels.
• Cervical and thoracic facet services are one CPT region. The regional frequency and code hierarchy must be applied accordingly.
• Thoracic level mapping requires precision because pain may overlap with costovertebral, costotransverse, rib, disc, myofascial, visceral, and radicular sources. The assessment should explain why the requested facet level and side are clinically plausible.
• Junctional levels such as C7-T1 and T12-L1 require careful regional classification, code selection, and payer-policy verification. Carelon currently excludes routine thoracic facet interventions except at C7-T1 and T12-L1, while other payers may apply different regional rules.
• The requested RFA levels must correspond to the joint levels established by the diagnostic MBBs.

Back to procedure navigation

4

Procedure Library

Distinguishing Thoracic MBB from Related Procedures

Procedure	Target	Typical purpose	Operational distinction
Thoracic medial branch block	Medial branch nerves supplying thoracic facet joints	Diagnostic or prognostic test before RFA	Requires payer-level coverage verification, precise joint-level mapping, laterality, response measurement, and downstream RFA intent.
Thoracic intra-articular facet joint injection	Facet joint capsule and intra-articular space	Limited diagnostic pathway or narrow therapeutic exception	Medicare generally prefers MBB when RFA is contemplated; payer coverage varies.
Thoracic medial branch radiofrequency ablation	Thoracic medial branch nerves	Longer-duration denervation after qualifying blocks	Requires successful diagnostic MBBs and explicit payer coverage of thoracic RFA.
Costovertebral or costotransverse joint injection	Rib-vertebral articulation	Evaluation or treatment of rib-joint pain	Different anatomy and authorization pathway; do not use facet codes or documentation interchangeably.
Thoracic epidural steroid injection	Epidural space	Thoracic radicular pain or radiculopathy	Different target, indication, CPT family, documentation, and frequency rules.
Trigger point injection	Myofascial trigger point	Myofascial pain	Does not establish thoracic facet-mediated pain or qualify the patient for facet RFA.

Authorization integrity rule The order must identify thoracic medial branch block, diagnostic or prognostic intent, exact joint level, side, planned image guidance, injectate category, and whether thoracic radiofrequency ablation is under consideration. Generic language such as thoracic facet injection is insufficient.

Back to procedure navigation

5

Procedure Library

Clinical Indications and Patient Selection

The best-supported authorization scenario is chronic, moderate to severe, predominantly axial thoracic or mid-back pain that causes measurable functional limitation, persists despite noninvasive care, and is not better explained by thoracic radiculopathy, myelopathy, fracture, tumor, infection, significant deformity, discogenic pain, costovertebral or costotransverse pathology, rib pathology, visceral disease, or another pain generator. Facet loading, focal paraspinal tenderness, painful restricted rotation or extension, and a compatible referral pattern may support selection, but no single examination maneuver proves the diagnosis.

Initial diagnostic MBB scenario

• Predominantly axial thoracic or mid-back pain with a clinically plausible facet distribution and no dominant chest-wall, visceral, radicular, or myelopathic pattern.
• Pain duration meeting the controlling policy, commonly at least three months.
• Moderate to severe symptoms that impair activities of daily living, work, sleep, sitting, standing, rotation, lifting, self-care, or other specific functions.
• Completed or contraindicated noninvasive conservative treatment with dates, modalities, adherence, and response.
• No untreated radiculopathy or neurologic condition that better explains the symptoms.
• Imaging or clinical evaluation excludes fracture, tumor, infection, significant deformity, or another dominant pain generator when required.
• Radiofrequency ablation is being considered if the diagnostic pathway is successful.
• The requested level and side are supported by the history, examination, imaging context, and prior procedure history.

Confirmatory diagnostic MBB scenario

• The first block was performed at the same level and side requested for confirmation.
• The first block met the payer-defined response threshold, commonly at least 80% relief of the index pain.
• The duration of relief was consistent with the local anesthetic used.
• The same baseline and post-block pain scale was used.
• The patient tested previously painful movements or activities during the diagnostic window.
• The requested interval meets the payer rule or a documented clinical exception is available.
• The treating clinician still intends to proceed to RFA if the confirmatory block is positive.

Therapeutic MBB scenario

Therapeutic medial branch blocks are substantially more restricted than diagnostic blocks. Medicare may cover therapeutic facet injections, including MBB, only after two successful diagnostic procedures, documented durable benefit, and a reason RFA cannot be performed. UnitedHealthcare and BCBS Michigan classify therapeutic MBBs as unproven, investigational, or not medically necessary. Carelon lists therapeutic MBB with corticosteroid as not medically necessary. Never submit a therapeutic MBB based only on temporary benefit from a diagnostic block; identify the exact covered exception and controlling policy.

Back to procedure navigation

6

Procedure Library

Contraindications and Safety Considerations

Contraindications and precautions are clinician-determined. Administrative workflows should verify that the record addresses relevant risk without substituting payer review for medical judgment. Thoracic MBB is performed near the spinal canal, pleura, ribs, vascular structures, and segmental nerves. Level-specific anatomy, image guidance, anticoagulation management, injectate volume, respiratory status, and sedation decisions require careful clinical planning.

• Active systemic infection or local infection at the access site.
• Uncorrected bleeding disorder or anticoagulant or antiplatelet management inconsistent with the clinician-approved plan.
• Uncontrolled medical instability or inability to safely cooperate with the procedure.
• Allergy or prior severe reaction requiring a modified medication or contrast plan.
• Progressive neurologic deficit, thoracic myelopathy, significant radiculopathy, or another condition requiring a different care pathway.
• Dynamic instability or significant spondylolisthesis when excluded by the controlling guideline.
• A prior fusion at the proposed level when the payer excludes MBB at fused segments.
• Routine moderate or deep sedation that may compromise diagnostic validity or lacks separate medical necessity.
• Use of large injectate volumes that could spread to adjacent structures and reduce diagnostic specificity.
• Routine addition of corticosteroid when the request is intended to be a diagnostic local-anesthetic block.

Back to procedure navigation

7

Procedure Library

Medical Necessity Requirements

Required element	What the record should show	Denial risk when missing
Pain pattern	Predominantly axial thoracic or mid-back pain; location, laterality, duration, severity, aggravating factors, referral pattern, and competing chest-wall or visceral symptoms.	Case is interpreted as nonspecific mid-back pain, radiculopathy, rib-joint pain, myofascial pain, or a non-spinal condition.
Functional deficit	Specific ADL, work, sleep, sitting, standing, lifting, rotation, self-care, or activity limitation with baseline pain and disability measurement.	No objective basis for intervention or later outcome comparison.
Examination	Facet loading or other concordant findings, neurologic assessment, and absence of a more compelling pain generator.	Insufficient clinical suspicion of facetogenic pain.
Conservative care	Dates, modalities, adherence, duration, response, and documented contraindications.	Failure of required noninvasive care is not established.
Imaging and exclusions	Relevant imaging date and findings when required; no fracture, tumor, infection, significant deformity, or dominant nerve-root pathology.	Competing pathology is not excluded.
Level and laterality	Exact joint level and side to be tested, with clinical rationale.	Authorization, procedure note, and claim cannot be reconciled.
Intent	Diagnostic or prognostic MBB with RFA under consideration.	Payer interprets the request as unsupported therapeutic injection.
Prior response	Baseline score, post-block score, percent relief, duration, anesthetic used, and functional activity tested.	Confirmatory block or RFA cannot be supported.
Frequency history	All facet procedures in the combined cervical/thoracic CPT region during the look-back period, plus any thoracic level exclusions under the plan.	Session limit or duplicate-service denial.
Image guidance and sedation	Fluoroscopy or CT planned; sedation absent or separately justified.	Noncovered guidance or sedation denial.

Back to procedure navigation

8

Procedure Library

Conservative Treatment and Care-Pathway Sequencing

Most payers require a documented trial of conservative care before the first diagnostic MBB. Medicare LCDs generally require pain for at least three months with failure of noninvasive conservative management as tolerated. Commercial policies may use four or six weeks of recent treatment, three months of symptoms, or plan-specific combinations. The record should show treatment delivered, not merely a statement that conservative care failed.

• Physical therapy or a physician-directed home exercise program with prescription date, target region, duration, adherence, and follow-up.
• Medication management when appropriate, including non-opioid analgesics or anti-inflammatory treatment.
• Activity modification, posture and movement training, ergonomic intervention, heat, cold, or other tolerated modalities.
• Chiropractic care or other plan-recognized treatment when clinically appropriate.
• Documented contraindication, intolerance, worsening, lack of access, or medical reason a modality could not be completed.
• Reassessment confirming persistent pain and functional limitation despite the completed plan.
• Continuation of a comprehensive pain-management strategy rather than an injection-only pathway.

Sequencing principle

The clinical and authorization sequence should be planned before the first block: verify that the member policy covers thoracic MBB at the requested level; complete the initial diagnostic MBB; perform a confirmatory block if required; request thoracic medial branch RFA only when the payer covers thoracic denervation and both block results meet the controlling criteria; and track outcomes for future care. A change in level, laterality, region, diagnosis, or delegated UM entity should trigger a new policy review.

Back to procedure navigation

9

Procedure Library

CMS National Guidance and NCD Review

Medicare does not have a procedure-specific National Coverage Determination that independently establishes national coverage criteria for routine thoracic MBB. Coverage is governed by the reasonable-and-necessary standard, Medicare manuals, the applicable MAC LCD, and the related billing and coding article. The absence of an NCD does not establish automatic coverage, and the operative MAC language must be checked because some LCD wording is framed around neck or low-back pain while the policy and code family also address thoracic facet interventions.

National authority	Operational relevance
Social Security Act Section 1862(a)(1)(A)	The service must be reasonable and necessary for diagnosis or treatment.
Social Security Act Section 1833(e)	The claim and medical record must contain sufficient information to determine payment.
Medicare Claims Processing Manual	Controls claim reporting, bilateral services, imaging, and other payment requirements.
National Correct Coding Initiative	Controls code combinations, bundling, and modifier use.
CMS Hospital Outpatient Prior Authorization Program	May require provisional affirmation for applicable facet codes performed in a hospital outpatient department.
Applicable MAC LCD and article	Establish medical necessity, diagnostic response, frequency, level, modifier, and diagnosis requirements for the beneficiary jurisdiction.

Back to procedure navigation

10

Procedure Library

Medicare LCD Requirements

Active Medicare facet LCDs use a substantially similar framework, but the practice must identify the exact LCD and billing article governing the beneficiary and place of service. L33930 is one active example and recognizes cervical, thoracic, and lumbar facet denervation within the policy structure. Do not treat one LCD or article as a national diagnosis list.

Core Medicare criteria

• Moderate to severe chronic thoracic or mid-back pain that is predominantly axial and causes a functional deficit measured on a pain or disability scale.
• Pain present for at least three months with documented failure of noninvasive conservative care as tolerated.
• Absence of untreated radiculopathy or neurogenic claudication, except radiculopathy caused by a facet synovial cyst.
• No non-facet pathology that better explains the pain, including fracture, tumor, infection, or significant deformity.
• Baseline pain assessment and disability scale, with the same pain scale used after each diagnostic procedure.
• Fluoroscopy or CT guidance. Facet procedures performed without guidance, with ultrasound, or with MRI guidance are not covered under the cited LCD.
• Only one spinal region per session and generally one or two levels, unilateral or bilateral, per session per region.
• No routine predetermined series.
• Routine moderate or deep sedation, general anesthesia, and monitored anesthesia care are not considered reasonable and necessary for facet injections.
• Medical necessity for multiple interventional pain procedures on the same day must be separately documented.

First and confirmatory diagnostic MBB

The first diagnostic MBB requires the general facet criteria. A second confirmatory diagnostic procedure at the same level may be covered when the first produced a consistent positive response of at least 80% relief of the index pain, with duration consistent with the local anesthetic. The cited LCD generally requires a minimum two-week interval, with case-specific exceptions documented. No more than four diagnostic facet sessions per covered spinal region are considered reasonable and necessary in a rolling 12 months.

Therapeutic MBB under Medicare

Therapeutic facet injections, including MBB, require two medically necessary diagnostic procedures with at least 80% relief after each, at least 50% pain relief for at least three months or at least 50% functional improvement after prior therapeutic treatment, and documentation explaining why the patient is not a candidate for RFA. No more than four therapeutic facet sessions per region are reimbursed in a rolling 12 months. This is a narrow pathway and should not be presented as routine therapy.

Source: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33930&ver=49

Back to procedure navigation

11

Procedure Library

Medicare Billing and Coding Articles and MAC Variation

The companion billing article is as important as the LCD because it controls diagnosis lists, laterality, KX use, level counting, coding hierarchy, utilization parameters, and documentation. A57787 is the current article paired with L33930. Other MACs use different article numbers and may have different supported diagnoses or modifier conventions. The practice must verify the live article for the beneficiary jurisdiction.

Article control	Example requirement from A57787	Operational action
Level counting	Count the facet joint level, not the number of nerves injected.	Reconcile order, authorization, procedure note, and claim by joint level.
Laterality	Use RT or LT for unilateral treatment and modifier 50 for bilateral treatment. Missing laterality may cause claim rejection.	Build laterality into intake, authorization, charge capture, and claim edits.
Regions	Cervical and thoracic are one CPT region.	Count all cervical and thoracic facet sessions together when applying regional rules.
Covered levels	One or two levels, unilateral or bilateral, are allowed per session per region.	Do not schedule or bill three covered Medicare levels based only on the existence of CPT 64492.
KX	Append KX to all diagnostic injections when policy requirements are met.	Use only after clinical verification; aberrant KX use may trigger review.
Image guidance	Fluoroscopy or CT is included in the facet code. Ultrasound is not covered.	Do not separately report bundled imaging guidance.
ASC bilateral reporting	Physician and facility bilateral reporting conventions differ.	Use payer and facility-specific claim edits.
Utilization	Facet injection codes are limited to four sessions per region per rolling 12 months under the article.	Maintain a complete regional procedure history before authorization and billing.
Diagnosis	Only the article-listed diagnoses support medical necessity for the covered codes.	Do not assume a commercial diagnosis list applies to Medicare.
Documentation	Signed records, relevant history, test results, scales, and selected code support must be available.	Use a pre-submission and pre-bill documentation checklist.

Source: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57787

Back to procedure navigation

12

Procedure Library

Medicare Hospital Outpatient Prior Authorization

CMS includes selected facet joint interventions in the prior authorization program for certain hospital outpatient department services. This program is separate from ordinary MAC medical-necessity review and is place-of-service dependent. The current code list, submission channel, documentation requirements, decision timeframe, resubmission process, and exemption status must be checked before scheduling.

• Confirm that the service will be performed in a hospital outpatient department and that the requested code is on the current CMS list.
• Submit the documentation supporting the live LCD and billing article, not a generic office note.
• Retain the provisional affirmation decision and tracking information in the authorization and billing record.
• A provisional affirmation does not guarantee payment; eligibility, benefits, coding, medical necessity, and claim requirements still apply.
• Reconcile authorization validity, rendering provider, facility, date, level, laterality, and code before the procedure.

Source: https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/prior-authorization-pre-claim-review-initiatives/prior-authorization-certain-hospital-outpatient-department-services

Back to procedure navigation

13

Procedure Library

Commercial Payer Policies

Commercial policies may group intra-articular facet injections and MBBs under one code family while applying different clinical intent rules. The practice must verify whether the payer requires prior authorization, whether review is delegated, whether one or two diagnostic blocks are required, the positive-response threshold, the allowed number of levels, conservative-care duration, injectate restrictions, and whether RFA must be under consideration.

Payer or policy	Relevant 2026 position	Operational consequence
UnitedHealthcare Commercial and Individual Exchange	Initial diagnostic facet injection or MBB may be covered when policy criteria are met. The 2026 policy defines a positive diagnostic MBB as at least 50% pain relief for the expected anesthetic duration and requires individual functional improvement for the second block. Therapeutic cervical, thoracic, and lumbar facet/MBB injections are unproven and not medically necessary.	Document facet loading, pain at least 3/10 after four weeks of conservative care, absence of competing pathology or fusion at the segment, RFA intent, exact level and side, local-anesthetic volume no greater than 0.5 mL, and complete pain and functional response.
Aetna CPB 0016	Initial IA or MBB from C2-C3 through L5-S1 may be diagnostic when severe chronic pain and policy criteria are met. A second same-level diagnostic block requires 80% relief for the expected anesthetic duration.	Separate diagnostic local-anesthetic intent from therapeutic steroid use. Verify the current conservative-care and RFA requirements in the live bulletin.
Commercial plans using proprietary criteria	Requirements may differ by product, employer group, state mandate, and benefit design.	Save the exact policy, effective date, code list, and authorization record for every case.
Medicare Advantage	The plan may apply Medicare criteria, plan policy, or delegated criteria within Medicare coverage rules.	Verify whether the request is reviewed by the plan, Carelon, eviCore, Cohere, Evolent, or another vendor.

Source: https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/facet-joint-injections-spinal-pain.pdf

Source: https://www.aetna.com/cpb/medical/data/1_99/0016.html

Back to procedure navigation

14

Procedure Library

BCBS Policy Variation

Blue Cross Blue Shield plans are independent organizations. There is no single national BCBS rule for thoracic MBB. One plan may use a plan-authored policy, another may delegate to Carelon or eviCore, and another may apply Medicare criteria for Medicare Advantage. Thoracic coverage is especially variable, so product, state, group, junctional level, and delegation must be identified before clinical review.

• BCBS Michigan states that diagnostic MBBs are established when criteria are met and classifies therapeutic MBBs as experimental and investigational.
• Some Blue plans use thresholds in the 75% to 80% range to reduce false-positive diagnostic blocks.
• Blue Cross NC archived selected spine policies for commercial products effective January 1, 2026 and directs affected services to Carelon criteria.
• Federal Employee Program members may be governed by a separate FEP medical policy manual.
• Out-of-area members may require home-plan or host-plan coordination.
• The plan benefit and vendor guideline must both be reviewed; vendor approval does not independently establish benefit coverage.

Source: https://www.bcbsm.com/amslibs/content/dam/public/mpr/mprsearch/pdf/83032.pdf

Source: https://www.bluecrossnc.com/providers/policies-guidelines-codes/notifications/commercial-medical-notification-12-16-2025

Back to procedure navigation

15

Procedure Library

Carelon, eviCore, Cohere, and Evolent

Carelon Medical Benefits Management

Carelon Interventional Pain Management criteria effective June 14, 2026 exclude diagnostic or therapeutic intra-articular facet injection, MBB, and RFA in the thoracic region, except at C7-T1 and T12-L1. For the covered cervical or lumbar pathways and the specified junctional exceptions, Carelon requires local anesthetic only for diagnostic MBB, dual blocks at least one week apart, at least 80% relief of the index pain with duration consistent with the anesthetic, and no routine steroid. This is a major authorization control: a technically appropriate thoracic MBB may still be noncovered when Carelon governs the member and the requested level is not C7-T1 or T12-L1.

Source: https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/

eviCore by Evernorth

eviCore CMM-201 applies only to the clients and effective dates identified in the document. The Cigna-specific 2026 version states that MBB is generally more appropriate than intra-articular injection for diagnosing facet pain, defines a positive response as at least 80% relief for the expected anesthetic duration, requires a second block to confirm the first positive response when RFA is being considered, permits only two diagnostic blocks at the same level and side, and uses fluoroscopy or CT. The guideline may allow up to three contiguous levels, which differs from Medicare. Never apply an eviCore rule to a non-eviCore product or assume all eviCore clients use the same edition.

Source: https://www.evicore.com/sites/default/files/clinical-guidelines/2026-04/Cigna_CMM-201%20Facet%20Joint%20Inj%20Med%20Block_V1.0.2026_Eff08.04.2026_Pub04.17.2026.pdf

Cohere Health

Cohere manages musculoskeletal prior authorization for selected plans, but its public provider resources do not establish one universal thoracic MBB policy. Confirm that the payer has delegated the requested CPT code and thoracic level, then save the plan-specific portal criteria, required questions, and decision record when permitted.

Source: https://www.coherehealth.com/provider/resources

Evolent and RadMD

Evolent publishes client and line-of-business specific interventional pain criteria. Its 2026 guideline for paravertebral facet injections or blocks describes image-guided MBB, conservative-care requirements, repeat-injection logic, and an RFA pathway after a successful MBB. The published guideline references at least 70% pain relief or improved function when considering RFA, which differs from Medicare, Carelon, and eviCore 80% pathways. Client addenda may supersede or modify the general guideline. Verify the health-plan implementation, code delegation, and effective date.

Source: https://www1.radmd.com/sites/default/files/2026-05/2026%20Evolent%20Interventional%20Pain%20Management%20Guidelines.pdf

Back to procedure navigation

16

Procedure Library

Clinical Evidence and Specialty-Society Guidance

Clinical evidence and payer policy answer different questions. Evidence informs diagnostic validity, prognostic value, technique, and patient selection. Payer policy determines whether the service is covered for a specific member and product. A clinical guideline may support a 50% response threshold or single-block pathway, while the payer may require two blocks with at least 80% relief. The authorization team must clearly separate evidence discussion from coverage requirements.

Thoracic evidence and specialty guidance

The thoracic evidence base is smaller than the cervical and lumbar evidence base. Published studies include controlled diagnostic-block cohorts, comparative studies of thoracic intra-articular injection and MBB, and longer-term studies of thoracic medial branch blocks. These studies inform clinical practice but do not create uniform payer coverage. The limited evidence is one reason some payers cover thoracic MBB cautiously and others exclude it except at junctional levels.

Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8639967/

ASIPP 2020 facet guidelines

ASIPP 2020 reports level II evidence with moderate strength of recommendation for thoracic diagnostic facet nerve blocks using controlled comparative local anesthetics and high pain-relief thresholds in the included studies. The guideline also discusses thoracic therapeutic nerve blocks, but payer coverage for therapeutic MBB remains substantially more restrictive than the clinical literature.

Source: https://asipp.org/wp-content/uploads/2020/11/REF1MA1.pdf

NASS and other policy recommendations

NASS coverage recommendations cited by CMS and UnitedHealthcare support dual diagnostic blocks with high relief thresholds before RFA. Payer summaries should not be presented as a substitute for the underlying NASS publication or live payer policy, but they help explain why dual blocks and 80% relief remain common coverage requirements.

Evidence limitations

• History, physical examination, and imaging cannot reliably identify a painful thoracic facet joint without diagnostic testing, and competing rib, costovertebral, costotransverse, disc, myofascial, radicular, and visceral sources must be considered.
• Single blocks may have false-positive results from placebo response, anesthetic spread, sedation, reduced activity, or nonspecific effects.
• A higher response threshold may reduce false positives but may also exclude some patients who could respond to RFA.
• Technique, injectate volume, target accuracy, outcome timing, and activity during the diagnostic window affect interpretation.
• Thoracic evidence should not be generalized from cervical or lumbar studies without qualification.
• A payer-defined positive response is a coverage rule, not a universal clinical truth.

Back to procedure navigation

17

Procedure Library

Policy and Guideline Comparison Matrix

Source	Initial MBB	Confirmatory block and response	Levels, guidance, and key limits
Medicare LCD and article example	General facet criteria; diagnostic MBB is the preferred routine diagnostic route.	Second same-level procedure generally at least two weeks later after at least 80% relief consistent with anesthetic.	Fluoroscopy or CT; one or two levels per region per session; no more than four diagnostic sessions per region in rolling 12 months; KX and laterality requirements.
UnitedHealthcare 2026	Diagnostic facet injection or MBB when policy criteria are met.	Second same-level and same-side block after a positive response, defined in the 2026 policy as at least 50% pain relief for the expected anesthetic duration plus individual functional improvement.	Check live coverage criteria, product applicability, levels, and authorization delegation. Therapeutic MBB is unsupported.
Aetna CPB 0016	Initial IA or MBB from C2-C3 through L5-S1 when severe chronic pain and policy criteria are met.	Second same-level block after 80% relief for expected anesthetic duration.	Verify current conservative-care, imaging, and RFA intent requirements.
Carelon 2026	Thoracic facet intervention is generally excluded except at C7-T1 and T12-L1. At those junctional levels, apply the diagnostic MBB pathway with local anesthetic only.	Dual blocks at least one week apart, each with at least 80% relief consistent with anesthetic, when the junctional exception applies.	Routine thoracic MBB, IA injection, and RFA are not medically necessary outside C7-T1 and T12-L1; ultrasound, steroid MBB, prior fusion level, and multiple regions same session are also excluded.
eviCore CMM-201 2026	MBB generally preferred; chronic axial pain, conservative care, RFA considered.	Second block confirms at least 80% response; only two diagnostic blocks at same level and side.	Fluoroscopy or CT; up to three contiguous levels under the cited client guideline; client-specific.
BCBS Michigan 2026	Diagnostic MBB established when criteria are met.	High response threshold used in supporting policy discussion; exact criteria must be checked.	Therapeutic MBB is experimental and investigational.
Evolent 2026	Image-guided MBB after clinical and conservative-care criteria.	Published guideline discusses RFA after successful MBB with at least 70% pain relief or functional improvement.	Client addenda and plan implementation control; published criteria differ from 80% pathways.
Cohere	No single public universal rule.	Plan-specific portal criteria.	Verify delegated codes, product, response threshold, and documentation prompts.

Back to procedure navigation

18

Procedure Library

Prior Authorization Workflow

1. Identify the payer, member product, benefit status, network, delegated UM entity, authorization channel, and intended place of service.

2. Confirm whether CPT 64490 and 64491 require prior authorization and whether Medicare hospital outpatient prior authorization applies.

3. Retrieve the live policy, LCD, billing article, vendor guideline, code list, and effective date. Save them to the case record.

4. Clarify the requested service as thoracic medial branch block, not generic facet injection, intra-articular injection, occipital nerve block, or RFA.

5. Confirm diagnostic or prognostic intent, exact joint level, side, target nerves, and planned injectate category.

6. Document that RFA is under consideration if required by the payer.

7. Validate chronicity, predominantly axial pain, functional deficit, examination, neurologic status, and exclusion of competing pathology.

8. Validate conservative-care dates, modalities, adherence, response, and contraindications.

9. Count all cervical and thoracic facet sessions in the payer look-back period, including MBB, IA, cyst procedures, and RFA when the policy defines the region or session broadly.

10. For a confirmatory request, capture the first block date, code, level, side, anesthetic, baseline score, post-block score, percent relief, duration, and functional activity tested.

11. Reconcile the requested RFA level map with the diagnostic MBB levels before submitting the second block.

12. Reconcile rendering provider, facility, requested dates, units, laterality, and authorization validity.

13. Submit an indexed clinical packet or concise policy-mapped summary.

14. Track requests for information, peer-to-peer deadlines, appeal rights, and authorization expiration.

15. Before the procedure, reconcile the authorization with the schedule and physician order.

16. After the procedure, reconcile the procedure note and claim and capture outcomes immediately for the next decision.

Back to procedure navigation

19

Procedure Library

Clinical Documentation Requirements

Initial diagnostic request

• Chief complaint, onset, duration, location, laterality, severity, and predominantly axial pattern.
• Specific functional limitations and baseline pain or disability instrument.
• Physical examination with facet loading or other concordant findings and neurologic assessment.
• Relevant thoracic imaging date and findings when required, including exclusion of fracture, tumor, infection, significant deformity, or dominant nerve-root pathology.
• Conservative treatment dates, components, adherence, response, and exceptions.
• Exact requested facet joint level and side.
• Diagnostic or prognostic intent and how the result will change management.
• Statement that thoracic medial branch RFA is under consideration if required.
• Planned fluoroscopic or CT guidance.
• Planned local anesthetic and whether steroid will be omitted for a diagnostic block.
• Relevant infection, anticoagulation, allergy, and sedation assessment.
• Prior facet procedure history in the cervical or thoracic region.

Confirmatory diagnostic request

• Date, level, side, CPT, and type of the first diagnostic block.
• Baseline and post-procedure pain scores using the same scale.
• Calculated percent relief of the index pain.
• Duration of relief compared with the expected anesthetic action.
• Medication name and concentration used for the first block.
• Specific functional activities performed during the diagnostic window.
• Confirmation that the same level and side are being requested.
• Required interval since the initial procedure or documented exception.
• Continued intent to proceed to RFA if the confirmatory block is positive.
• Explanation when a different level is requested because the initial block was negative or inconclusive.

Procedure report

• Pre- and post-procedure diagnosis and indication.
• Diagnostic, prognostic, or narrowly supported therapeutic intent.
• Exact thoracic joint level and laterality evaluated.
• Medial branch targets used to evaluate the documented thoracic joint level.
• Image-guidance method and contrast findings when used.
• Medication name, concentration, and volume at each target.
• Sedation, if any, and separate medical necessity.
• Complications and disposition.
• Immediate pain score and functional testing instructions.
• Outcome diary or follow-up process and planned next step.

Post-block outcome record

• Baseline index pain immediately before the block.
• Post-block pain scores at clinically appropriate intervals.
• Percent pain relief calculated from the same scale.
• Onset and duration of relief.
• Previously painful movements or activities tested during the anesthetic window.
• Medication and duration expected from the anesthetic used.
• Adverse effects, sedation effects, or activity restriction that could confound interpretation.
• Physician interpretation and next-step plan.

Back to procedure navigation

20

Procedure Library

Documentation Pearls

• Use thoracic medial branch block consistently. Do not alternate among facet injection, IA injection, nerve block, and MBB without explaining the distinction.
• Document the joint level being evaluated, not only the nerves targeted.
• For junctional procedures, identify whether the treated joint is C7-T1 or T12-L1 and verify the payer-specific regional, code, and coverage rule before authorization and billing.
• State that RFA is under consideration before the first block when the payer requires it.
• Capture the baseline scale before the block. It cannot be reconstructed reliably after a denial.
• Document percent relief, duration, anesthetic, and activity testing. The words positive block or helped are insufficient.
• Avoid routine steroid language in a diagnostic MBB request when the payer requires local anesthetic only.
• Do not rely on imaging degeneration alone. Connect the level to the history, examination, and excluded alternatives.
• Reconcile authorization, order, schedule, procedure note, outcome record, and claim by route, level, side, and intent.
• Do not use a lower clinical response threshold in an authorization that requires 80% without acknowledging the policy conflict.

Back to procedure navigation

21

Procedure Library

CPT and HCPCS Coding

Code	General descriptor role	Thoracic MBB application	Operational control
64490	Paravertebral facet joint or nerves innervating the joint, cervical or thoracic, first level, with fluoroscopy or CT.	Report the first treated thoracic facet level, unilateral or bilateral. For T12-L1, verify the MAC or payer code-boundary instruction.	Image guidance is included. The code can describe IA or MBB, so the procedure note must identify MBB.
64491	Cervical or thoracic second level add-on code.	Report a second distinct thoracic joint level in the same cervical/thoracic CPT region when supported and covered.	Use only with the required primary code and verify bilateral and unit logic.
64492	Cervical or thoracic third and additional level add-on code.	CPT recognizes a third or additional cervical/thoracic level, but Medicare generally does not cover three- or four-level sessions.	Medicare generally considers three- or four-level sessions noncovered. Commercial coverage varies. Do not infer coverage from code existence.
0213T-0215T	Category III codes for ultrasound-guided cervical or thoracic facet procedures.	May describe ultrasound-guided thoracic facet or MBB services in selected settings, but Medicare and several payers exclude ultrasound guidance.	Medicare and several payer policies exclude ultrasound-guided facet interventions. Verify coverage before use.
64633 and 64634	Cervical or thoracic medial branch radiofrequency ablation codes.	Downstream cervical/thoracic RFA codes after qualifying thoracic MBBs and payer approval.	Do not use for the diagnostic block. RFA authorization must match the MBB-established levels and sides.

Coding boundaries

• Count the number of facet joints evaluated, not the number of medial branch nerves injected.
• A bilateral procedure at one level remains one level for code hierarchy, with payer-specific bilateral reporting.
• Cervical and thoracic are one CPT region.
• Fluoroscopy or CT is included in CPT 64490-64492 and is not separately reported.
• The third and additional level code may be valid CPT but noncovered under a specific payer policy.
• Verify regional boundaries carefully at C7-T1 and T12-L1. Do not infer the CPT region or payer pathway from the needle target alone; align the billed joint level, authorization, and controlling policy.
• Verify the current CPT edition and payer-specific code edits for the date of service.

Back to procedure navigation

22

Procedure Library

ICD-10-CM Crosswalk

The diagnosis must describe the documented condition and must be accepted by the controlling payer or MAC article. A diagnosis code does not establish medical necessity by itself. Medicare diagnosis lists vary by MAC and may be narrower than commercial policies.

ICD-10-CM	Description	Operational use or caution
M47.814	Spondylosis without myelopathy or radiculopathy, thoracic region	Common Medicare-supported thoracic code when the record establishes axial facet-mediated pain and no untreated radiculopathy.
M47.815	Spondylosis without myelopathy or radiculopathy, thoracolumbar region	Use when the documented condition and treated joint are thoracolumbar, including payer-recognized junctional scenarios.
M47.894	Other spondylosis, thoracic region	Use only when documentation supports other thoracic spondylosis and the live policy accepts it.
M47.895	Other spondylosis, thoracolumbar region	Use for supported thoracolumbar other-spondylosis scenarios.
M48.14	Ankylosing hyperostosis [Forestier], thoracic region	Listed in selected Medicare articles; the clinical presentation and facet indication must still be established.
M48.15	Ankylosing hyperostosis [Forestier], thoracolumbar region	Use only when documented and accepted by the controlling article.
M54.6	Pain in thoracic spine	May be accepted by some commercial plans but is nonspecific and may not appear on the Medicare article diagnosis list.
M47.24	Other spondylosis with radiculopathy, thoracic region	Untreated radiculopathy generally argues against routine diagnostic MBB. Do not use as the sole justification for facet MBB.
M53.84	Other specified dorsopathies, thoracic region	In selected Medicare articles this code is reserved for facet cyst injection or aspiration, not routine MBB or RFA.

ICD-10-CM integrity warning

Do not select a diagnosis solely because it appears on a payer list. The record must support the highest level of specificity, and the diagnosis must correspond to the service performed. Verify the current ICD-10-CM year and the exact MAC or payer policy before claim submission.

Back to procedure navigation

23

Procedure Library

Modifiers, Units, NCCI, MUE, and Place of Service

Control	Operational guidance
RT and LT	Use for unilateral treatment when required. The level and side in the claim must match the authorization and procedure report.
Modifier 50	Commonly used by the physician for bilateral treatment at the same level. Confirm payer and facility conventions.
KX	Required for diagnostic injections under selected Medicare articles when policy requirements are met. Do not append automatically.
Units	Report code units based on payer rules. Do not multiply units by the number of nerves used to evaluate one joint.
NCCI	Review current edits for bundled imaging, sedation, other injections, and same-day services.
MUE	Verify current medically unlikely edits and payer-specific unit limits for the date of service.
Office	Confirm payer authorization and site-of-service rules. The professional code includes image guidance.
ASC	Physician and ASC facility bilateral reporting may differ. Build separate claim edits.
Hospital outpatient	Confirm CMS or payer prior authorization and site-of-service review.
Multiple procedures	Same-day epidural, trigger point, sympathetic, or other spine procedures may be denied unless separately necessary and clearly documented.
Sedation	Routine moderate or deep sedation and MAC are not covered for Medicare facet injections; commercial policies may also restrict sedation.

Back to procedure navigation

24

Procedure Library

Reimbursement Considerations

• Prior authorization does not guarantee payment. Eligibility, benefits, network, coding, documentation, timely filing, and claim edits remain separate requirements.
• The first-level and add-on code hierarchy must match the number of joint levels evaluated.
• Bilateral reporting errors are a common cause of rejection, underpayment, or duplicate denial.
• Image guidance is included and should not be unbundled.
• A third-level code may be valid under CPT but noncovered under Medicare or a commercial policy.
• A diagnostic MBB claim may require KX under the applicable MAC article.
• The authorization may be issued for MBB but the procedure note may read facet injection or include steroid, creating post-service review risk.
• Facility and professional claims must use consistent levels, laterality, date, and diagnosis.
• Published fee schedules should be checked for the payer, locality, place of service, and date of service. Do not use national averages as a substitute for contract analysis.
• Track denials and underpayments by code, payer, vendor, site of service, laterality, and reason to identify systemic defects.

Back to procedure navigation

25

Procedure Library

Denial Prevention

Failure mode	Prevention control
Generic facet terminology	Require the order to state thoracic MBB, diagnostic or prognostic intent, exact level, side, and RFA plan.
RFA intent missing	Add a required field confirming whether RFA is under consideration.
Pain pattern not axial	Route cases with dominant radiculopathy, myelopathy, rib-joint pain, chest-wall symptoms, or possible visceral disease to physician clarification before submission.
Conservative care incomplete	Use date-specific documentation and obtain follow-up showing response or inability to complete.
Level or side mismatch	Reconcile the order, prior block, authorization, schedule, procedure note, and claim before service.
First block response incomplete	Use a structured outcome form with baseline score, post-score, percent relief, duration, activity, and anesthetic.
Response below payer threshold	Do not submit the confirmatory block or RFA as though the threshold was met. Obtain physician review and document the actual result.
Steroid used in diagnostic block	Verify vendor injectate rules before procedure and keep the operative note aligned with diagnostic intent.
Thoracic level excluded	Verify plan and delegated UM coverage before scheduling. Carelon excludes routine thoracic intervention except C7-T1 and T12-L1.
Frequency exceeded	Maintain a regional procedure ledger across MBB, IA, RFA, and cyst procedures.
Ultrasound selected	Verify coverage; use fluoroscopy or CT when required.
Prior fusion level	Check whether the payer excludes the fused segment and whether adjacent-level criteria are met.
Same-day multiple procedures	Require separate medical necessity and payer confirmation before combining services.
Bilateral coding error	Use payer-specific physician and facility edits for modifier 50, RT, and LT.

Back to procedure navigation

26

Procedure Library

Common Denial Reasons and Corrective Actions

Denial reason	What to investigate	Corrective action
Not medically necessary	Did the record establish chronic axial pain, function loss, conservative care, exclusions, and RFA intent?	Map the appeal to each controlling criterion and submit the missing evidence.
Radiculopathy or another pain generator	Was the case actually facet-mediated or did documentation emphasize nerve-root symptoms?	Clarify the clinical diagnosis, neurologic findings, imaging, and why MBB remains appropriate.
Second block denied	Did the first block meet threshold, duration, level, side, and interval requirements?	Submit the structured outcome record and policy-mapped chronology.
RFA intent absent	Was RFA under consideration before the first block?	Provide the contemporaneous treatment plan; avoid retrospective unsupported language.
Conservative therapy not documented	Were dates, modalities, duration, adherence, and response included?	Submit therapy notes, home-exercise prescription and follow-up, medication history, and exceptions.
Thoracic level or payer exclusion	Does the payer cover thoracic MBB, and is the level a permitted junctional exception when Carelon applies?	Correct the request or appeal only when the live policy, benefit, or documented exception supports the requested thoracic level.
Prior fusion exclusion	Was the requested level fused or adjacent?	Submit imaging and operative history and apply the payer-specific adjacent-level rule.
Therapeutic MBB excluded	Was steroid used or was the request described as long-term treatment?	Clarify diagnostic intent if accurate; otherwise identify a covered exception or revise the care plan.
Authorization mismatch	Do code, level, side, date, provider, facility, and intent match?	Correct the authorization before claim submission when possible.
Diagnosis not covered	Does the diagnosis appear in the applicable article or plan policy?	Use the accurate supported diagnosis or appeal with policy evidence; never code solely for coverage.
KX or laterality missing	Was the claim submitted under a MAC requiring KX and specific laterality?	Correct the claim in accordance with the live article and payer rules.

Back to procedure navigation

27

Procedure Library

Appeals and Peer-to-Peer Preparation

An appeal should not repeat the office note. It should identify the controlling policy, quote or paraphrase each relevant criterion, show where the record satisfies it, and directly resolve the denial rationale. When the policy does not support the request, escalation should be based on a legitimate medical-necessity exception or benefit argument, not a generic statement that the procedure is standard of care.

Appeal packet

• Denial notice, authorization record, reference number, deadline, and appeal rights.
• Member benefit and controlling policy or guideline with effective date.
• Concise physician letter identifying thoracic MBB, level, side, intent, and downstream RFA plan.
• History, functional limitation, examination, imaging context, and conservative-care chronology.
• Prior block procedure report and structured outcome record when applicable.
• Medication and injectate details showing diagnostic local-anesthetic intent.
• Policy comparison when the reviewer applied the wrong product, vendor, region, threshold, or level limit.
• Relevant clinical guideline only after the controlling coverage argument is addressed.
• Requested remedy, such as reversal, corrected authorization, peer review, or expedited reconsideration.

Peer-to-peer questions

• Which exact policy, version, and effective date is being applied?
• Is the reviewer treating this as MBB, intra-articular injection, occipital nerve block, or therapeutic injection?
• Does the policy require one or two diagnostic blocks?
• What response threshold and interval apply?
• Is RFA intent required and is it documented?
• What level and laterality did the reviewer interpret from the record?
• Is the denial based on radiculopathy, prior fusion, number of levels, conservative care, or another exclusion?
• Was the correct plan product and delegated UM entity used?
• What specific document would resolve the denial?
• If the policy conflicts with the clinical presentation, is an exception process available?

Back to procedure navigation

28

Procedure Library

Workflow Optimization and Quality Controls

Workflow stage	Control
Intake	Require procedure, intent, joint level, side, payer, product, place of service, and RFA plan.
Policy research	Save the live policy, LCD, article, vendor guideline, code list, effective date, and access date.
Clinical review	Use a thoracic MBB-specific checklist that includes competing thoracic pain generators and payer-level coverage verification.
Prior-history review	Search all cervical and thoracic facet sessions, prior thoracic blocks and RFA, fusion history, and delegated-vendor decisions.
Outcome capture	Use a structured diagnostic-block form completed during the expected anesthetic window.
Authorization	Reconcile code, level, side, units, provider, facility, and date range.
Scheduling	Block scheduling when authorization or clinical data do not match the physician order.
Procedure report	Use standardized fields for level, side, target nerve, image guidance, medication, volume, and immediate response.
Charge capture	Verify code hierarchy, bilateral modifier, KX, units, and diagnosis.
Claim edit	Check NCCI, MUE, same-day services, authorization validity, and place-of-service rules.
Next-step decision	Route positive blocks to confirmatory MBB or RFA according to payer policy; route negative or equivocal blocks to physician review.
Audit	Compare authorization, procedure note, outcome record, and claim for every high-risk payer or denial trend.

Back to procedure navigation

29

Procedure Library

Operational KPIs

KPI	Definition	Why it matters
Clean submission rate	Percent of requests submitted without missing policy-required elements	Measures intake and documentation discipline.
First-pass approval rate	Percent approved without additional information, peer-to-peer, or appeal	Shows policy alignment.
Confirmatory-block conversion rate	Percent of initial MBBs meeting the payer threshold for a second block	Measures patient selection and outcome capture.
RFA qualification rate	Percent of completed diagnostic pathways qualifying for RFA	Shows pathway effectiveness and payer-rule alignment.
Outcome capture completion	Percent with complete baseline, post-score, percent, duration, activity, and anesthetic	Prevents confirmatory and RFA denials.
Level and side discrepancy rate	Percent with mismatch among order, authorization, note, and claim	Identifies a high-risk revenue-integrity defect.
Additional-information rate	Percent requiring payer requests for missing clinical data	Reveals preventable documentation gaps.
Peer-to-peer rate	Percent requiring physician review	Measures avoidable escalation burden.
Denial rate by reason	Denials segmented by medical necessity, threshold, levels, frequency, coding, and authorization	Directs corrective action.
Appeal overturn rate	Percent of appealed denials reversed	Measures appeal quality and original-denial preventability.
Authorization-to-claim match rate	Percent with exact alignment of code, level, side, date, provider, and facility	Protects reimbursement.
Time to decision	Days from complete intake to payer determination	Supports capacity planning and patient access.

Back to procedure navigation

30

Procedure Library

Payer Perspective

From the payer perspective, a thoracic MBB is valuable only when it answers a defined diagnostic question and the member policy actually covers the requested thoracic level. The reviewer is looking for a credible axial thoracic pain pattern, appropriate conservative care, exclusion of competing pathology, a precise level and side, an authorized RFA pathway, and reliable post-block measurement. Requests that appear to be routine injections, broad multilevel testing, therapeutic steroid blocks, or procedures excluded by the delegated vendor are likely to be denied.

Back to procedure navigation

31

Procedure Library

Clinical Pearls

• No history, examination, or imaging finding alone confirms thoracic facet pain.
• MBB is generally more predictive than intra-articular injection for selecting patients for thoracic RFA.
• Use low-volume local anesthetic for diagnostic specificity according to clinician judgment and applicable guidance.
• Avoid routine sedation when diagnostic interpretation depends on the patient response.
• Thoracic and junctional levels require precise terminology, level mapping, and differentiation from costovertebral, costotransverse, rib, epidural, and myofascial procedures.
• A technically negative block should prompt reconsideration of level, pain generator, technique, and confounding factors before repeating.
• The clinically preferred response threshold may differ from the payer threshold. Both should be documented accurately.
• Therapeutic MBB is not interchangeable with a diagnostic block and is excluded by many commercial policies.
• The RFA request should be anticipated before the first block so that levels, sides, scales, and outcome capture remain consistent.

Back to procedure navigation

32

Procedure Library

GoHealthcare Perspective

Thoracic MBB is an operational episode, not a single authorization. The episode begins with coverage verification because thoracic level eligibility varies materially by payer and delegated UM entity. It continues through accurate intake, policy research, clinical documentation, block outcome capture, confirmatory testing, RFA decision-making, procedure notes, and claim alignment.

GoHealthcare recommends a pathway-based work queue that links the first MBB, second MBB, and potential RFA under one case record. Each step should have a policy checklist, level and side map, procedure history, outcome record, authorization status, deadline, and next-action owner. This structure reduces preventable peer-to-peer reviews, denials, and lost revenue while improving patient access.

Back to procedure navigation

33

Procedure Library

GoHealthcare Insights

• The most valuable field in the intake form is not the CPT code. It is the intended pathway: diagnostic MBB to possible RFA.
• The highest-risk documentation gap is an incomplete response record after the first block.
• The same patient may meet a clinical guideline but fail a payer rule because the threshold, number of blocks, or level limit differs.
• Commercial authorization vendors change versions and client implementations. Policy date and product delegation should be stored with the case.
• A single regional procedure ledger prevents many frequency and duplicate denials.
• Level mapping should be reviewed by clinical staff before authorization and again before billing.
• Do not let a positive response disappear into free text. Structured data makes the second authorization and RFA request faster and defensible.
• When the payer does not cover therapeutic MBB, repeated diagnostic coding creates audit risk rather than a sustainable treatment pathway.
• Case-study links and Request Help CTAs should convert the procedure library from a static reference into an operational lead-generation asset.

Back to procedure navigation

34

Procedure Library

Frequently Asked Questions

Is a thoracic MBB the same as a thoracic facet joint injection?

No. An MBB targets the medial branch nerves supplying the thoracic facet joint. An intra-articular injection targets the joint itself. The same CPT family may describe either route, so documentation must specify the procedure performed.

What is the main purpose of thoracic MBB?

Its main purpose is diagnostic or prognostic identification of thoracic facet-mediated pain before RFA when the member policy covers thoracic denervation.

Which CPT code reports the first thoracic level?

CPT 64490 is used for the first cervical or thoracic facet level with fluoroscopy or CT.

What code reports the second thoracic level?

CPT 64491 is the add-on code for a second cervical or thoracic level.

Can CPT 64492 be billed for a third thoracic level?

CPT recognizes the code, but Medicare generally does not cover three- or four-level facet sessions. Commercial coverage varies and must be verified.

Does Medicare require two diagnostic blocks before RFA?

The cited Medicare LCD pathway requires two diagnostic procedures, with the first producing at least 80% relief before the confirmatory procedure. Verify the beneficiary-specific LCD.

What is a positive MBB?

The definition is payer-specific. Medicare, Carelon, eviCore, Aetna, and many other policies use at least 80% relief for the expected anesthetic duration. Other clinical or payer pathways may use a lower threshold.

How long must relief last?

The relief should be consistent with the expected duration of the local anesthetic used. The record should document onset, duration, and activity during the diagnostic window.

Is steroid appropriate in a diagnostic MBB?

Many diagnostic pathways expect local anesthetic only. Carelon specifically requires local anesthetic without steroid for the dual blocks used before RFN. Steroid may cause the request to be interpreted as therapeutic.

Can ultrasound be used?

Clinical literature discusses ultrasound in selected cases, but Medicare and several payer policies exclude ultrasound-guided facet interventions. Verify the controlling policy.

Is fluoroscopy separately billable?

No. Fluoroscopy or CT guidance is included in CPT 64490-64492.

Can the block be performed bilaterally?

Yes, when clinically indicated and covered. Bilateral reporting and level counting must follow payer rules.

How are levels counted when two nerves supply one joint?

Count the joint level evaluated, not the number of nerves or needles.

Why are C7-T1 and T12-L1 important?

C7-T1 and T12-L1 are junctional levels that can affect regional classification, code selection, and coverage. Carelon currently identifies these as exceptions to its broader thoracic facet-intervention exclusion. Other payers may classify or cover them differently, so the live member-specific policy controls.

Can thoracic MBB be performed at a fused level?

Some payer policies exclude MBB at a prior fusion level and may allow only adjacent-level evaluation. Verify the live policy and operative history.

Can radiculopathy support a thoracic MBB?

Routine facet pathways generally require predominantly axial pain without untreated thoracic radiculopathy or myelopathy. A policy-recognized exception must be identified if neurologic symptoms are present.

Can MBB be therapeutic?

Medicare has a narrow therapeutic pathway when RFA cannot be performed, but many commercial policies consider therapeutic MBB unproven or investigational.

What documentation is most often missing?

The first-block response: baseline score, post-block score, percent relief, duration, anesthetic, and functional activity tested.

Does prior authorization guarantee payment?

No. Benefits, eligibility, network, coding, documentation, claim edits, and authorization-to-claim alignment still determine payment.

Can a confirmatory block use a different level?

A confirmatory block is generally performed at the same level. A different level may represent a new diagnostic question and requires separate clinical and payer review.

How soon can the second block be performed?

Medicare generally uses a minimum two-week interval, with documented case-specific exceptions. Commercial vendors may use different intervals.

What happens after two positive blocks?

The patient may qualify for thoracic medial branch RFA only if the payer covers thoracic denervation at the requested level and all diagnostic-block, response, level-mapping, and documentation requirements are met.

Are repeat blocks required before repeat RFA?

Many policies do not require repeat diagnostic blocks when a prior RFA produced sufficient durable relief and the same pain recurs. Verify the payer rule.

How should a denial be appealed?

Use the exact policy, map each criterion to the record, address the denial reason directly, and include the structured prior-block outcome when relevant.

Back to procedure navigation

35

Procedure Library

Related Procedures

• Thoracic Intra-Articular Facet Joint Injection
• Cervical Medial Branch Block
• Lumbar Medial Branch Block
• Thoracic Medial Branch Radiofrequency Ablation
• Cervical Medial Branch Radiofrequency Ablation
• Lumbar Medial Branch Radiofrequency Ablation
• Thoracic Interlaminar Epidural Steroid Injection
• Thoracic Transforaminal Epidural Steroid Injection
• Costovertebral and Costotransverse Joint Injection
• Trigger Point Injection

Back to procedure navigation

36

Procedure Library

References and Related Readings

CMS. Facet Joint Interventions for Pain Management LCD L33930. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33930&ver=49

CMS. Billing and Coding: Facet Joint Interventions for Pain Management A58403, current version effective May 21, 2026. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=58403

CMS. Prior Authorization for Certain Hospital Outpatient Department Services. https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/prior-authorization-pre-claim-review-initiatives/prior-authorization-certain-hospital-outpatient-department-services

CMS. National Correct Coding Initiative. https://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits

UnitedHealthcare. Facet Joint and Medial Branch Block Injections for Spinal Pain, effective May 1, 2026. https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/facet-joint-injections-spinal-pain.pdf

Aetna. Clinical Policy Bulletin 0016: Back Pain - Invasive Procedures. https://www.aetna.com/cpb/medical/data/1_99/0016.html

Carelon Medical Benefits Management. Interventional Pain Management, effective June 14, 2026. https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/

eviCore by Evernorth. CMM-201 Facet Joint Injections and Medial Branch Blocks, 2026 client edition. https://www.evicore.com/sites/default/files/clinical-guidelines/2026-04/Cigna_CMM-201%20Facet%20Joint%20Inj%20Med%20Block_V1.0.2026_Eff08.04.2026_Pub04.17.2026.pdf

Cohere Health. Provider Resources and Review Criteria. https://www.coherehealth.com/provider/resources

Evolent. 2026 Interventional Pain Management Guidelines. https://www1.radmd.com/sites/default/files/2026-05/2026%20Evolent%20Interventional%20Pain%20Management%20Guidelines.pdf

Blue Cross Blue Shield of Michigan. Facet Joint Denervation Medical Policy, 2026. https://www.bcbsm.com/amslibs/content/dam/public/mpr/mprsearch/pdf/83032.pdf

Blue Cross NC. Commercial Medical Policy Notification effective January 1, 2026. https://www.bluecrossnc.com/providers/policies-guidelines-codes/notifications/commercial-medical-notification-12-16-2025

Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V, Fellows B. The role of thoracic medial branch blocks in managing chronic mid and upper back pain: a randomized, double-blind, active-control trial with 2-year follow-up. https://pmc.ncbi.nlm.nih.gov/articles/PMC3407605/

Manchikanti L, et al. ASIPP Comprehensive Evidence-Based Guidelines for Facet Joint Interventions. https://asipp.org/wp-content/uploads/2020/11/REF1MA1.pdf

GoHealthcare Practice Solutions. Case Study Library. https://www.gohealthcarellc.com/case-studies.html

GoHealthcare Practice Solutions. Request Help. https://www.gohealthcarellc.com/contact-us.html

Back to procedure navigation

Strengthen Thoracic Medial Branch Block Authorization and Revenue Integrity

GoHealthcare supports physician practices, ASCs, hospitals, and healthcare organizations with prior authorization, utilization management, clinical documentation review, denial prevention, appeals, coding alignment, and revenue-cycle operations for complex musculoskeletal procedures.

Request Help View Case Studies

Case Study Library: https://www.gohealthcarellc.com/case-studies.html

!

Disclaimer

This publication is provided for healthcare operations, education, and general informational purposes. It is not medical advice, legal advice, coding advice, reimbursement advice, or a guarantee of coverage or payment. Payer policies, Medicare requirements, coding rules, and clinical guidelines change and may vary by member, product, plan, state, delegated utilization-management entity, Medicare Administrative Contractor, place of service, and date of service. Verify the current member benefit, live payer policy, applicable CMS guidance, LCD, billing and coding article, CPT and ICD-10-CM code sets, NCCI edits, authorization requirements, and contractual terms before providing or billing a service. Clinical decisions remain the responsibility of the treating licensed clinician.